Thank you for you interest in the work of Fighting Blindness, it means the world.
Because of you, our supporters, we are ever closer to the goal of finding treatments and cures for blindness. This can only be achieved with your help and sustained investment into pioneering research across Ireland. Thanks to your commitment and dedication, we get closer with every day while continuing to supporting people and families through our national counselling service and peer to peer support groups.
Fighting Blindness Income:
• Public Funding 10%
These sources comprise funding from the HSE to support our Counselling Service and co-financing funding through the Health Research Board (HRB) for specific research projects.
• Fundraising & Donations 90%
We rely so much on the support of the community and businesses to help us raise 90% of our annual each year. Funds are raised through a mix of regular giving donations, community fundraisers, corporate support and events & challenges.
Where your important donation is used:
Our three expenditure priority areas are those identified in our Strategic Plan – A Vision for the Future. These are:
- Cure – investment in research
In 2015 we invested €692,618 in vital vision research, and have commitments for ongoing projects for 2016 and beyond. This investment supports research projects including, gene and cell therapies, compound therapies, population studies. All of these projects are based in Ireland.
- Support – investment in the Insight Counselling Service
In 2015 our Insight Counselling Service cost €118,907 – providing a professional counselling service to people affected by sight loss and their families. This service is currently available in Leinster and Muster, and available nationally through a telephone counselling service (01 674 6496).
- Empower – investment in education, outreach and advocacy
In 2015 we invested €136,024 in the empowerment of our members and communities through education and the provision of information. As treatments and cures get closer to clinical trials the investment in education and advocacy becomes ever more important. We strive to enhance links and bridge the gap between patients and organisations and companies involved in potential therapies.